144 related articles for article (PubMed ID: 19645083)
1. Telaprevir for chronic HCV infection.
Kao JH
N Engl J Med; 2009 Jul; 361(5):534; author reply 534-5. PubMed ID: 19645083
[No Abstract] [Full Text] [Related]
2. [Treatment of chronic hepatitis viral C: new associations].
Ouzan D
Presse Med; 2013 Jun; 42(6 Pt 1):977-82. PubMed ID: 23021659
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of telaprevir, pegylated interferon α-2b and ribavirin triple therapy in Japanese patients infected with hepatitis C virus genotype 1b.
Kawaguchi Y; Iwane S; Kumagai T; Yanagita K; Yasutake T; Ide Y; Otsuka T; Eguchi Y; Ozaki I; Akiyama T; Kawazoe S; Mizuta T
Intern Med; 2015; 54(20):2551-60. PubMed ID: 26466688
[TBL] [Abstract][Full Text] [Related]
4. Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis.
Cooper C; Lester R; Thorlund K; Druyts E; El Khoury AC; Yaya S; Mills EJ
QJM; 2013 Feb; 106(2):153-63. PubMed ID: 23159839
[TBL] [Abstract][Full Text] [Related]
5. Telaprevir and peginterferon with or without ribavirin for chronic HCV infection.
Hézode C; Forestier N; Dusheiko G; Ferenci P; Pol S; Goeser T; Bronowicki JP; Bourlière M; Gharakhanian S; Bengtsson L; McNair L; George S; Kieffer T; Kwong A; Kauffman RS; Alam J; Pawlotsky JM; Zeuzem S;
N Engl J Med; 2009 Apr; 360(18):1839-50. PubMed ID: 19403903
[TBL] [Abstract][Full Text] [Related]
6. Telaprevir: a review of its use in the management of genotype 1 chronic hepatitis C.
Perry CM
Drugs; 2012 Mar; 72(5):619-41. PubMed ID: 22439668
[TBL] [Abstract][Full Text] [Related]
7. Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.
McHutchison JG; Everson GT; Gordon SC; Jacobson IM; Sulkowski M; Kauffman R; McNair L; Alam J; Muir AJ;
N Engl J Med; 2009 Apr; 360(18):1827-38. PubMed ID: 19403902
[TBL] [Abstract][Full Text] [Related]
8. Sustained virological response after 4 weeks of telaprevir, peginterferon, and ribavirin in an Asian patient with genotype 1 chronic hepatitis C and IL28B genotype CC.
Brulotte N; Hahn H; Lee M
Dig Dis Sci; 2014 Apr; 59(4):737-9. PubMed ID: 24114049
[No Abstract] [Full Text] [Related]
9. Telaprevir alone or with peginterferon and ribavirin reduces HCV RNA in patients with chronic genotype 2 but not genotype 3 infections.
Foster GR; Hézode C; Bronowicki JP; Carosi G; Weiland O; Verlinden L; van Heeswijk R; van Baelen B; Picchio G; Beumont M
Gastroenterology; 2011 Sep; 141(3):881-889.e1. PubMed ID: 21699786
[TBL] [Abstract][Full Text] [Related]
10. Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial.
Reddy KR; Zeuzem S; Zoulim F; Weiland O; Horban A; Stanciu C; Villamil FG; Andreone P; George J; Dammers E; Fu M; Kurland D; Lenz O; Ouwerkerk-Mahadevan S; Verbinnen T; Scott J; Jessner W
Lancet Infect Dis; 2015 Jan; 15(1):27-35. PubMed ID: 25482330
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis in 2010: the dawn of a new era in HCV therapy.
Ciesek S; Manns MP
Nat Rev Gastroenterol Hepatol; 2011 Feb; 8(2):69-71. PubMed ID: 21293503
[TBL] [Abstract][Full Text] [Related]
12. Peg-interferon plus ribavirin with or without boceprevir or telaprevir for HCV genotype 1: a meta-analysis on the role of response predictors.
Coppola N; Pisaturo M; Sagnelli C; Sagnelli E; Angelillo IF
PLoS One; 2014; 9(4):e94542. PubMed ID: 24728219
[TBL] [Abstract][Full Text] [Related]
13. Telaprevir for retreatment of HCV infection.
Zeuzem S; Andreone P; Pol S; Lawitz E; Diago M; Roberts S; Focaccia R; Younossi Z; Foster GR; Horban A; Ferenci P; Nevens F; Müllhaupt B; Pockros P; Terg R; Shouval D; van Hoek B; Weiland O; Van Heeswijk R; De Meyer S; Luo D; Boogaerts G; Polo R; Picchio G; Beumont M;
N Engl J Med; 2011 Jun; 364(25):2417-28. PubMed ID: 21696308
[TBL] [Abstract][Full Text] [Related]
14. Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
Zeuzem S
J Hepatol; 2008 Aug; 49(2):157-9. PubMed ID: 18554745
[No Abstract] [Full Text] [Related]
15. The efficacy and safety of telaprevir-based regimens for treating chronic hepatitis C virus genotype 1 infection: a meta-analysis of randomized trials.
Yang D; Liang HJ; Li D; Wei X; Ma L; Jia Z
Intern Med; 2013; 52(6):653-60. PubMed ID: 23503406
[TBL] [Abstract][Full Text] [Related]
16. [Telaprevir, PEG-IFNα-2b and ribavirin combination therapy for difficult to treat patients with genotype 2 chronic hepatitis C].
Nishimura T
Nihon Rinsho; 2015 Dec; 73 Suppl 9():193-8. PubMed ID: 26845929
[No Abstract] [Full Text] [Related]
17. Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.
Buti M; Agarwal K; Horsmans Y; Sievert W; Janczewska E; Zeuzem S; Nyberg L; Brown RS; Hézode C; Rizzetto M; Paraná R; De Meyer S; De Masi R; Luo D; Bertelsen K; Witek J
Gastroenterology; 2014 Mar; 146(3):744-753.e3. PubMed ID: 24316262
[TBL] [Abstract][Full Text] [Related]
18. Impact of ribavirin on HCV replicon RNA decline during treatment with interferon-α and the protease inhibitors boceprevir or telaprevir.
Hofmann WP; Chung TL; Osbahr C; Susser S; Karey U; Mihm U; Welsch C; Lötsch J; Sarrazin C; Zeuzem S; Herrmann E
Antivir Ther; 2011; 16(5):695-704. PubMed ID: 21817191
[TBL] [Abstract][Full Text] [Related]
19. [Is 24 weeks of peginterferon and ribavirin combination therapy sufficient for the patients with genotype 1 chronic hepatitis C?].
Song BC
Korean J Gastroenterol; 2010 Jul; 56(1):59-61. PubMed ID: 20664319
[No Abstract] [Full Text] [Related]
20. ADVANCE study begins enrollment.
AIDS Patient Care STDS; 2008 Apr; 22(4):345. PubMed ID: 18422463
[No Abstract] [Full Text] [Related]
[Next] [New Search]
